substandard medicines
Factors Influencing Clinical Trial Site Selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study)
December 04 by Pharmaceuticals & Biotechnology EditorThe SAT-EU study group, an independent non-profit collaborative initiative, supported by the European Forum for Good Clinical Practice (EFGCP) and several other trade and not-for profit organisation...
Standardising Serialisation: The Deadly World of Falsified and Substandard Medicines
June 18 by Andrea CharlesJust in the last few months, another dangerous fake drug made its way into the United States, a bogus version of the cancer drug Avastin surfaced in clinics across America in California, Ill...
What if the Medication that was Supposed to Keep you Alive was Actually Killing You?
June 15 by Pharma IQ NewsIn a chilling new book Roger Bate blows the whistle on what could be America’s greatest health crisis. “Phake: The Deadly World of Falsified and Substandard Medicines” reveals how ruthless criminals p...